Today: 21 May 2026
Bitcoin price edges higher near $91,000 as Strategy buys $1.25B of BTC; Coinbase stock climbs

Bitcoin price edges higher near $91,000 as Strategy buys $1.25B of BTC; Coinbase stock climbs

New York, Jan 12, 2026, 12:45 EST — Regular session

Bitcoin edged up Monday, along with a group of bitcoin-related stocks, as traders balanced a new Strategy buying surge against broader jitters over the Federal Reserve.

The token climbed roughly 0.3% to $91,147. Coinbase (COIN) jumped 2.0%, and Strategy (MSTR) ticked up 2.1%. Miners Marathon Digital (MARA) surged 4.4%, with Riot Platforms (RIOT) edging up 1.3%.

The scene changed late Sunday when Fed Chair Jerome Powell revealed the Justice Department had handed the central bank grand jury subpoenas and was threatening a criminal indictment. “On Friday, the Department of Justice served the Federal Reserve with grand jury subpoenas,” Powell confirmed. Reuters

Bitcoin’s back to behaving like a high-beta macro play—reacting sharply to interest rates, the dollar, and shifts in risk appetite. This week’s packed with key data and policy events. Tuesday brings the U.S. consumer price index report for December, followed by the Fed’s January 27-28 meeting.

According to an SEC filing, the strategy acquired 13,627 bitcoin from Jan. 5 to Jan. 11, spending roughly $1.25 billion and averaging $91,519 per coin including fees. The purchases were financed via an at-the-market program, selling new shares gradually. As of Jan. 11, it held 687,410 bitcoin.

This kind of buying can prop up bitcoin at the edges, but it also locks volatility into the stock. The shares tend to swing beyond the token’s moves, both on the upside and the downside.

After Powell’s remarks, the dollar took a hit. Marc Chandler, chief market strategist at Bannockburn Global Forex in New York, remarked: “This just ended the dollar’s New Year bounce.” Reuters

Gold surged past $4,600 an ounce, hitting a new record as investors sought safety across multiple fronts. “Elevated uncertainty plays directly into the gold market,” said Michael Haigh, global head of commodities research at Societe Generale. Reuters

Rate chatter is heating up. J.P. Morgan now forecasts the Fed’s next rate hike in 2027, while Barclays and Goldman Sachs pushed their expected 2026 cuts further into the year, Reuters reported. Traders see a 95% chance the Fed holds rates steady at the January meeting, per CME’s FedWatch tool.

Crypto isn’t off the hook. If the CPI print comes in hotter than expected, Treasury yields and the dollar could climb again. That combo usually puts pressure on bitcoin and miners, who depend on steady financing and a stable coin price.

Bitcoin remains far from its early-October peak near $126,223, leaving a shadow over crypto-equity valuations once spot prices lose momentum.

Tuesday’s CPI report is the next key checkpoint for traders, ahead of the Fed’s Jan. 27-28 meeting and the policy announcement on Jan. 28. Any new developments regarding Powell’s position could either extend the “haven” trade or cause it to unravel quickly. FRED

Stock Market Today

  • EnerSys Q1 CY2026 Sales Beat Estimates with Optimistic Guidance
    May 20, 2026, 6:18 PM EDT. Battery maker EnerSys (NYSE:ENS) reported Q1 CY2026 sales of $988 million, up 1.4% year on year, beating analyst estimates by 1.5%. Adjusted earnings per share (EPS) stood at $3.19, a 6.6% beat over consensus. Guidance for Q2 revenue is $935 million, 2.2% above estimates, with adjusted EPS guidance also exceeding forecasts. Despite a 6% decline in sales volumes, revenue growth was supported by price increases. Free cash flow turned negative at -$12.66 million, down from $105 million last year. EnerSys continues to push its lithium data center and battery energy storage system solutions, signaling long-term innovation. The company's subdued 4.7% annualized revenue growth over five years contrasts with sector expectations, raising caution among investors.

Latest articles

Silexion Stock Almost Doubles: Cancer Trial Push, Cash Questions and Nasdaq Risk Drive SLXN Frenzy

Silexion Stock Almost Doubles: Cancer Trial Push, Cash Questions and Nasdaq Risk Drive SLXN Frenzy

21 May 2026
New York, May 20, 2026, 18:02 (EDT) Silexion Therapeutics Corp’s Nasdaq-listed shares nearly doubled on Wednesday, closing at $0.5298, up 96.95%, before slipping 9.5% in after-hours trading as the low-priced oncology stock drew more than 325 million shares in volume. The stock had ended Tuesday at $0.269. The move came after regular trading had ended in New York. Nasdaq’s normal session runs from 9:30 a.m. to 4:00 p.m. Eastern time, with after-hours trading available from 4:00 p.m. to 8:00 p.m.; May 20 was not a U.S. exchange holiday. The reason it matters now is simple enough: Silexion is trying to
AEVEX Stock Jumps After Hours as Drone Maker Posts 307% Revenue Surge and New Air Force Deal

AEVEX Stock Jumps After Hours as Drone Maker Posts 307% Revenue Surge and New Air Force Deal

21 May 2026
AEVEX Corp. shares surged over 10% after hours Wednesday following a first-quarter profit of $21 million and new U.S. Air Force contracts worth $15.6 million. Revenue jumped to $216.7 million, beating estimates. The company, which went public in April, raised its full-year revenue outlook to $600–$620 million. The stock had closed regular trading at $26.27, down 0.23%.
Jupiter Neurosciences Stock Swings on $100M MDMA Pact, $2M Equity Sale

Jupiter Neurosciences Stock Swings on $100M MDMA Pact, $2M Equity Sale

21 May 2026
Jupiter Neurosciences shares fell 37% to $0.205 Wednesday after announcing a proposed U.S. licensing deal for PharmAla Biotech’s MDMA-based ALA-002 and a $2 million stock offering. Trading volume topped 230 million shares. The licensing agreement is non-binding, with a potential value over $100 million, and gives Jupiter 90 days to finalize terms. Jupiter reported a $2.06 million Q1 net loss and $2.36 million in cash.
Dow Jones today: Index slips as Trump’s 10% credit-card cap hits banks, Powell subpoena clouds the Fed
Previous Story

Dow Jones today: Index slips as Trump’s 10% credit-card cap hits banks, Powell subpoena clouds the Fed

GDS Holdings stock jumps nearly 10% as China ADR rally keeps DayOne’s $2 billion funding in focus
Next Story

GDS Holdings stock jumps nearly 10% as China ADR rally keeps DayOne’s $2 billion funding in focus

Go toTop